Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OptiVia Medical is a specialized contract research organization (CRO) that provides industry-leading in vitro transporter models and services for drug discovery and development. The company focuses on drug-drug interaction (DDI) studies and transporter-mediated drug clearance, offering a vast portfolio of assays for Solute Carrier (SLC) and ATP-binding cassette (ABC) transporters. Their proprietary Opti-Expression technology allows for the evaluation of drug candidates' safety and efficacy profiles by analyzing how they interact with human transporters. OptiVia's services are critical for pharmaceutical companies seeking to comply with FDA and EMA regulatory guidelines regarding drug disposition. In July 2018, the company was acquired by Charles River Laboratories to bolster its ADME and discovery service capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OptiVia Medical.